The Board of Directors of I-Mab has authorized a buyback plan in August 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 USD | -2.75% | -2.21% | -6.84% |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.84% | 147M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I-Mab authorizes a Buyback Plan.